Cinoxacin: pharmacokinetics and the effect of probenecid. 1978

K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney

Cinoxacin is a new synthetic organic antibacterial compound which has a serum half-life of approximately 1 hour. Most of the drug is eliminated in man by the kidney, primarily as unchanged drug. The renal clearance of cinoxacin is slightly greater than the usually accepted value for the average glomerular filtration rate, which suggests that it is probably filtered and is also secreted by the tubule. Results after pretreatment with probenecid further suggest secretion of the drug.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D004148 Dioxolanes
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
January 1986, American journal of veterinary research,
K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
March 1979, Antimicrobial agents and chemotherapy,
K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
June 1983, Drug intelligence & clinical pharmacy,
K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
January 1982, Antimicrobial agents and chemotherapy,
K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
August 1983, The Journal of antimicrobial chemotherapy,
K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
June 1983, Antimicrobial agents and chemotherapy,
K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
January 1993, European journal of clinical pharmacology,
K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
May 1991, Journal of clinical pharmacology,
K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
January 1982, Therapie,
K S Israel, and H R Black, and R L Nelson, and M K Brunson, and J F Nash, and G L Brier, and J D Wolney
March 1989, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!